30 /100
MEDIUM RISK
Score updated Jun 14, 2026

AROC — Archrock, Inc. Dilution Risk Tracker

Track AROC dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track AROC — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
25
📊 Float Risk
2
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for AROC.
🔔 Track AROC — Get forecast alerts →

💹 Market Data

Market Cap$5.87B
Shares Outstanding175.26M
Float170.53M
Cash$4.46M
Debt$2.38B
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 5.1% shares (2026Q1 vs prior)
432 institutional holders · 191.50M shares
#1 BlackRock, Inc. 28.10M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 14.99M shares
#3 VANGUARD PORTFOLIO MANAGEMENT LLC 10.94M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest6.79M
Days to Cover3.4
% of Float4.0%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2016
4 INSIDER TRANSACTION Mar 31, 2026
4 INSIDER TRANSACTION Mar 05, 2026
4 INSIDER TRANSACTION Mar 03, 2026
4 INSIDER TRANSACTION Mar 02, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track AROC Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking AROC — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

🔬 More Research for AROC
📊 AROC FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 AROC Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.